Posaconazol

  • Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
    Related Articles

    Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.

    Eur J Med Chem. 2019 Aug 29;183:111660

    Authors: Braga SS

    Abstract
    This mini-review focuses on leishmanicidal drugs that were sourced from small molecules previously approved for other diseases. The mechanisms of action of these molecules are herein explored, to probe the origins of their inter-species growth inhibitory activities. It is shown how the transversal action of the azoles - fluconazole, posaconazole and itraconazole - in both fungi and Leishmania is due to the occurrence of the same target, lanosterol 14-α-demethylase, in these two groups of species. In turn, the drugs miltefosine and amphotericin B are presented as truly multi-target agents, acting on small molecules, proteins, genes and even organelles. Steps towards future leishmanicidal drug candidates based on the multi-target strategy and on drug repurposing are also briefly presented.

    PMID: 31514064 [PubMed - as supplied by publisher]


    > <>

Deja un comentario

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.